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cal laboratories to differentiate Streptococcus pneumoniae
(Pneumococci) from other -heamolytic streptococci. How-
ever, presence of optochin resistant pneumococci may lead
to misidentiﬁcation that will cause a compromise with treat-
ment and prevention of pneumococcal diseases. The typical
optochin susceptibility of Pneumococci resides in the Fo
complex of its FoF1 H+-ATPase, an ion transport enzyme that
is essential for the viability of this organism. Mechanism of
optochin resistance has been attributed to a single point
mutation in amino acid residues of the H+-ATPase c-subunit
(atpC).
Objective: To validate the preserved isolates and iden-
tify optochin-resistant pneumococci by bile solubility test
and PCR for lytA gene and to determine the mechanism of
optochin resistance.
Methodology: Alpha hemolytic streptococci isolated from
4,730 nasopharyngeal swabs of children <5 years old. The
isolates were validated by colony morphology, optochin sus-
ceptibility, bile solubility, PCR for lyt A (autolysin) and
ATPase c-subunit genes and sequencing to detect any AA
mutations.
Results: In total, 1618 -haemolytic isolates were vali-
dated; 111(6.86%) were Optr -heamolytic strains and only
37 (0.8%) were pneumococcus that were bile soluble and
possessed lytA gene. The PCR of atpC from all 37 strains
showed the presence of F0 complex in F0F1 H+-ATPase.
Sequencing of atpC gene of three strains when compared
with reference strain (opts strain R6) revealed the presence
of nucleotide change that produces AA substitution in ATPase
c-subunit protein.
Conclusion: Optochin resistant Streptococcus pneumo-
niae was ﬁrst observed in Bangladesh. A single point
mutation in H+-ATPase c-subunit gene that contributed for
Optr phenotype. Reporting of Opt pneumococci as viridans
streptococcus might have signiﬁcant implications for the
treatment and outcome of patients. Therefore, validation of
-haemolytic streptococci as pneumococci by bile solubility
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Background: Recent years have seen the emergence of
methicillin-resistant Staphylococcus aureus (MRSA) strains
often characterised by community acquisition, unusual
susceptibility to antimicrobials, and the Panton-Valentine
leukocidin (PVL) virulence factor. The epidemiology of these
strains varies between geographical locations. This study
aimed to determine the occurrence and clinical features
of such strains in the University of Malaya Medical Centre,
Kuala Lumpur.
Methods: Laboratory records were examined for MRSA
isolates from 2002—2007. Using CLSI disc diffusion stan-
dards, multisensitive MRSA was deﬁned as susceptibility to
erythromycin, clindamycin, fusidic acid, rifampicin, gen-
tamicin, ciproﬂoxacin, cotrimoxazole, and tetracycline. PCR
detection of mecA and PVL genes lukS-PV-lukF-PV, SCCmec
typing, and MLST were carried out. The PVL product was
conﬁrmed by sequencing. Only cases with isolates avail-
able for PCR conﬁrmation were included in clinical records
review. Centers for Diseases Control and Prevention crite-
ria were used to distinguish between community-associated
(CA-MRSA) and healthcare-associated MRSA.
Results: Multisensitive MRSA from 13 distinct patient-
episodes were identiﬁed; 1 in 2003, 2 in 2006, and 10 in 2007
(0.27%, 0.62%, and 3.1% of new MRSA cases, respectively). 9
isolates from 2007 were available for mecA conﬁrmation. Of
these, only 2 were PVL-positive CA-MRSA; the remaining 7
were healthcare-associated, of which 3 were PVL-positive.
All isolates were of SCCmec type IV. There were 3 isolates of
each sequence type (ST) ST30 and ST6, 1 ST22 strain, and 2
untypeable isolates. Clinical presentations included skin or
soft-tissue infections (6), probable colonisation (2 babies),
bacteraemia (1), and no deaths. All 4 isolates unavailable
for conﬁrmation were healthcare-associated.
Conclusion: We describe the ﬁrst conﬁrmed clinical infec-
tions with multisensitive, SCCmec type IV, PVL-positive MRSA
in Malaysia, which were mainly skin or soft-tissue infections.
In view of the predominance of healthcare-associated acqui-
sition, and the apparent increase in cases in 2007 (albeit
small numbers), further work including multilocus sequence




Antimicrobial Activity of Daptomycin Tested Against
Multidrug-Resistant Gram-Positive Strains Collected in
European Hospitals (2003—2007)
H. Sader ∗, T. Fritsche, M. Janechek, R. Jones
JMI Laboratories, North Liberty, IA, USA
Background: Daptomycin is a cyclic lipopeptide approved
for the treatment of complicated skin and soft tissue infec-
tions (cSSTI), right sided infective endocarditis (RIE) due to
Staphylococcus aureus (SA) and for SA bacteraemia when
associated with RIE or with cSSTI. We evaluated the activ-
ity of daptomycin and comparator agents tested against
multidrug-resistant (MDR) Gram-positive organisms isolated
in European hospitals.
Methods: 23,269 Gram-positive organisms were col-
lected through the Daptomycin Surveillance Program in
the 2003—2007 period, including SA (11,836), coagulase-
negative staphylococci (CoNS; 4,445), enterococci (4,464),
viridians group streptococci (VGS; 756) and beta-haemolytic
streptococci (BHS; 1,768). Isolates were consecutively col-
lected from patients with documented infections in 32
European hospitals (14 countries) and susceptibility tested
by CLSI broth microdilution methods against daptomycin and
>20 comparators. Mueller-Hinton broth was supplemented
to a 50mg/L calcium concentration for testing daptomycin.
MDR was deﬁned as resistance to drugs in 3 or more antimi-
crobial classes.
